Britain’s FTSE 100 .FTSE index is seen opening 42 points lower at 6,144 on Tuesday, according to financial bookmakers.
CONSUMERS: Consumer spending, a rare bright spot for Britain’s economy during the coronavirus pandemic, faded in October although the re-introduction of lockdowns prompted a renewed stockpiling spree, surveys showed.
REGULATOR: Britain’s accounting and corporate governance regulator called for global rules to improve how companies inform investors about how their activities relate to climate change and cutting carbon emissions.
ASTRAZENECA: An AstraZeneca AZN.L executive on Monday said he felt encouraged by “incredibly promising” COVID-19 vaccine trial data unveiled by Pfizer and its German partner BioNTech.
KAZ MINERALS: KAZ Minerals’ KAZ.L fifth-biggest investor says it plans to vote against a 3 billion pound ($3.94 billion) take-private plan orchestrated by the company’s chairman, Oleg Novachuk, because it undervalues it. BREXIT: Prime Minister Boris Johnson suffered a heavy defeat in parliament’s upper chamber on Monday over proposed laws that would allow him to breach the terms of Britain’s European Union exit treaty.
GOLD: Gold prices firmed after falling as much as 5.2% in the previous session, as hopes of more U.S. stimulus measures to cushion the COVID-19 pandemic hit bolstered the precious metal’s appeal as an inflation hedge.
OIL: Oil prices dropped as concerns over fuel demand in the near term in coronavirus-hit Europe and the United States returned to haunt the market after an overnight surge on progress towards a COVID-19 vaccine. The UK blue-chip index .FTSE closed 4.7% higher on Monday as signs of progress in developing a COVID-19 vaccine bolstered hopes of a swift economic recovery.